Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cerilliant
Cantor Fitzgerald
Dow
UBS
Novartis
Healthtrust
Colorcon
Federal Trade Commission
Farmers Insurance

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022048

« Back to Dashboard

NDA 022048 describes TRIESENCE, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the TRIESENCE profile page.

The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Pharmacology for NDA: 022048
Medical Subject Heading (MeSH) Categories for 022048
Suppliers and Packaging for NDA: 022048
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIESENCE triamcinolone acetonide INJECTABLE;INTRAVITREAL 022048 NDA Alcon Laboratories, Inc. 0065-0543 0065-0543-01 1 BLISTER PACK in 1 CARTON (0065-0543-01) > 1 VIAL, GLASS in 1 BLISTER PACK > 1 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVITREALStrength40MG/ML (40MG/ML)
Approval Date:Nov 29, 2007TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jan 13, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE FOR DELINEATION (VISUALIZATION) DURING A VITRECTOMY SURGICAL PROCEDURE
Patent:➤ SubscribePatent Expiration:Dec 17, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Mar 10, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF OPHTHALMIC DISORDERS

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Merck
Novartis
Healthtrust
Fish and Richardson
Julphar
QuintilesIMS
Queensland Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot